Related Experiment Videos
A new device to stabilize templates for transperineal I-125 implants
K Wallner1, S T Chiu-Tsao, J Roy
1Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Summary
Transperineal Iodine-125 prostate implants utilize CT planning and ultrasound for accuracy. A new device, the WIPI, enhances stability during this procedure, improving needle placement verification.
Area of Science:
- Oncology
- Medical Physics
- Surgical Technology
Background:
- Transperineal Iodine-125 implantation is a key treatment for prostate cancer.
- Accurate seed placement is crucial for effective treatment and minimizing side effects.
- Current methods rely on CT-based planning and transrectal ultrasound (TRUS) for verification.
Purpose of the Study:
- To introduce and describe the design of a novel adjustable device, the WIPI.
- To highlight the WIPI's role in stabilizing the perineal template and rectal obturator.
- To demonstrate the WIPI's utility during the planning and implantation phases of prostate brachytherapy.
Main Methods:
- Development of an adjustable device (WIPI) for procedural stabilization.
- Assessment of WIPI compatibility with CT scanning and transrectal ultrasound.
- Evaluation of WIPI integration with the Mick applicator for precise needle placement.
Main Results:
- The WIPI device provides stability for the perineal template and rectal obturator.
- The device is compatible with essential imaging and delivery technologies (CT, TRUS, Mick applicator).
- The WIPI is designed for ease of use during transperineal prostate implant procedures.
Conclusions:
- The WIPI device offers a simple and effective solution for stabilizing components during prostate brachytherapy.
- Its compatibility ensures seamless integration into existing clinical workflows.
- The WIPI has the potential to improve the accuracy and efficiency of transperineal Iodine-125 prostate implants.